PATENT CLAIM ANALYSIS

Application Number: 15760697
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "172100"]

Abstract:
Provided is a compound having formula (I): wherein R 2  is selected from —C 1 , —Br and —CN; R 1  and R 4  are independently selected from H and —F; R 631 , R 632 , R 641  and R 642  are independently selected from —H, —F and substituted or unsubstituted C 1 -C 3  alkyl groups; and R 651  and R 652  are independently selected from H and substituted or unsubstituted C 1 -C 3  alkyl groups and substituted or unsubstituted phenyl groups; and wherein at least one of R 631 , R 632 , R 641 , R 642  and R 652  is not —H, or wherein when all of R 631 , R 632 , R 641 , R 642  and R 652  are —H, R 651  is not Me or Et.

Claim (Index 30):
The method according to  claim 29 , wherein the disease or condition or disorder is a cancer selected from: a solid or liquid tumour including cancer of the eye, brain (such as gliomas, glioblastomas, medullablastomas, craniopharyngioma, ependymoma, and astrocytoma), spinal cord, kidney, mouth, lip, throat, oral cavity, nasal cavity, small intestine, colon, parathyroid gland, gall bladder, head and neck, breast, bone, bile duct, cervix, heart, hypopharyngeal gland, lung, bronchus, liver, skin, ureter, urethra, testicles, vagina, anus, laryngeal gland, ovary, thyroid, oesophagus, nasopharyngeal gland, pituitary gland, salivary gland, prostate, pancreas, adrenal glands; an endometrial cancer, oral cancer, melanoma, neuroblastoma, gastric cancer, an angiomatosis, a hemangioblastoma, a pheochromocytoma, a pancreatic cyst, a renal cell carcinoma, Wilms' tumour, squamous cell carcinoma, sarcoma, osteosarcoma, Kaposi sarcoma, rhabdomyosarcoma, hepatocellular carcinoma, PTEN Hamartoma-Tumor Syndromes (PHTS) (such as Lhermitte-Duclos disease, Cowden syndrome, Proteus syndrome, and Proteus-like syndrome), leukaemias and lymphomas (such as acute lymphoblastic leukaemia, chronic lymphocytic leukaemia, acute myelogenous leukaemia, chronic myelogenous leukaemia, hairy cell leukaemia, T-cell prolymphocytic leukemia (T-PLL), large granular lymphocytic leukemia, adult T-cell leukemia, juvenile myelomonocytic leukaemia, Hodgkin lymphoma, non-Hodgkin lymphoma, mantle lymphoma, follicular lymphoma, primary effusion lymphoma, AIDS-related lymphoma, Hodgkin lymphoma, diffuse B cell lymphoma, Burkitt lymphoma and cutaneous T-cell lymphoma).

Metadata:
- Claim Count in Document: 18.0
- Percentile: 90.0
- Lexical Diversity: 2.77358
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15504703', '15100494', '15105615', '15524142', '15301619']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7825176539401042
- 35 USC 102 Novelty (BERT): 0.5354462168626833
- Combined Prediction Score: 0.7578105102323622
- Mean Citation Score: 355.36224
- Max Citation Score: 374.16812
- Similarity Product: 272.171386552434

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test